nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—SLC6A3—bipolar disorder	0.301	0.401	CbGaD
Amphetamine—SLC6A4—bipolar disorder	0.225	0.3	CbGaD
Amphetamine—DRD2—bipolar disorder	0.224	0.299	CbGaD
Amphetamine—CARTPT—telencephalic ventricle—bipolar disorder	0.0183	0.18	CbGeAlD
Amphetamine—CARTPT—blood plasma—bipolar disorder	0.00871	0.0858	CbGeAlD
Amphetamine—SLC6A2—locus ceruleus—bipolar disorder	0.00799	0.0787	CbGeAlD
Amphetamine—SLC18A2—telencephalic ventricle—bipolar disorder	0.00621	0.0612	CbGeAlD
Amphetamine—SLC6A3—telencephalic ventricle—bipolar disorder	0.0047	0.0463	CbGeAlD
Amphetamine—CARTPT—adrenal cortex—bipolar disorder	0.00442	0.0436	CbGeAlD
Amphetamine—SLC6A2—autonomic nervous system—bipolar disorder	0.00425	0.0418	CbGeAlD
Amphetamine—DRD2—telencephalic ventricle—bipolar disorder	0.00345	0.034	CbGeAlD
Amphetamine—TAAR1—thyroid gland—bipolar disorder	0.00308	0.0303	CbGeAlD
Amphetamine—CARTPT—thyroid gland—bipolar disorder	0.00308	0.0303	CbGeAlD
Amphetamine—SLC18A2—blood plasma—bipolar disorder	0.00296	0.0292	CbGeAlD
Amphetamine—TAAR1—nervous system—bipolar disorder	0.00259	0.0255	CbGeAlD
Amphetamine—CARTPT—nervous system—bipolar disorder	0.00259	0.0255	CbGeAlD
Amphetamine—CARTPT—cerebellum—bipolar disorder	0.00244	0.024	CbGeAlD
Amphetamine—SLC6A4—blood plasma—bipolar disorder	0.00205	0.0202	CbGeAlD
Amphetamine—CARTPT—brain—bipolar disorder	0.00198	0.0195	CbGeAlD
Amphetamine—MAOB—blood plasma—bipolar disorder	0.00195	0.0192	CbGeAlD
Amphetamine—CYP2D6—urine—bipolar disorder	0.0019	0.0187	CbGeAlD
Amphetamine—SLC18A2—thyroid gland—bipolar disorder	0.00105	0.0103	CbGeAlD
Amphetamine—MAOB—adrenal cortex—bipolar disorder	0.00099	0.00975	CbGeAlD
Amphetamine—CYP2D6—blood plasma—bipolar disorder	0.000989	0.00974	CbGeAlD
Amphetamine—SLC18A2—nervous system—bipolar disorder	0.00088	0.00867	CbGeAlD
Amphetamine—SLC18A2—cerebellum—bipolar disorder	0.000829	0.00816	CbGeAlD
Amphetamine—SLC22A5—adrenal cortex—bipolar disorder	0.000778	0.00766	CbGeAlD
Amphetamine—SLC22A3—thyroid gland—bipolar disorder	0.000745	0.00734	CbGeAlD
Amphetamine—CYP2A6—cerebellum—bipolar disorder	0.00074	0.00729	CbGeAlD
Amphetamine—MAOB—thyroid gland—bipolar disorder	0.00069	0.00679	CbGeAlD
Amphetamine—SLC18A2—brain—bipolar disorder	0.000673	0.00663	CbGeAlD
Amphetamine—SLC6A3—nervous system—bipolar disorder	0.000666	0.00656	CbGeAlD
Amphetamine—SLC22A3—nervous system—bipolar disorder	0.000627	0.00618	CbGeAlD
Amphetamine—SLC6A3—cerebellum—bipolar disorder	0.000627	0.00617	CbGeAlD
Amphetamine—SLC6A4—nervous system—bipolar disorder	0.00061	0.00601	CbGeAlD
Amphetamine—Pargyline—MAOA—bipolar disorder	0.000606	0.0965	CrCbGaD
Amphetamine—CYP2A6—brain—bipolar disorder	0.000601	0.00592	CbGeAlD
Amphetamine—Diethylpropion—SLC6A3—bipolar disorder	0.000596	0.0948	CrCbGaD
Amphetamine—MAOB—nervous system—bipolar disorder	0.00058	0.00571	CbGeAlD
Amphetamine—MAOB—cerebellum—bipolar disorder	0.000546	0.00538	CbGeAlD
Amphetamine—SLC22A5—thyroid gland—bipolar disorder	0.000542	0.00534	CbGeAlD
Amphetamine—SLC6A2—nervous system—bipolar disorder	0.000537	0.00529	CbGeAlD
Amphetamine—SLC6A3—brain—bipolar disorder	0.000509	0.00501	CbGeAlD
Amphetamine—DRD2—nervous system—bipolar disorder	0.00049	0.00482	CbGeAlD
Amphetamine—SLC22A3—brain—bipolar disorder	0.000479	0.00472	CbGeAlD
Amphetamine—SLC6A4—brain—bipolar disorder	0.000466	0.00459	CbGeAlD
Amphetamine—DRD2—cerebellum—bipolar disorder	0.000461	0.00454	CbGeAlD
Amphetamine—Lisdexamfetamine—SLC6A3—bipolar disorder	0.000451	0.0718	CrCbGaD
Amphetamine—MAOB—brain—bipolar disorder	0.000443	0.00437	CbGeAlD
Amphetamine—SLC22A5—cerebellum—bipolar disorder	0.000429	0.00423	CbGeAlD
Amphetamine—SLC6A2—brain—bipolar disorder	0.000411	0.00404	CbGeAlD
Amphetamine—Tranylcypromine—MAOA—bipolar disorder	0.000391	0.0622	CrCbGaD
Amphetamine—DRD2—brain—bipolar disorder	0.000374	0.00369	CbGeAlD
Amphetamine—Phenylpropanolamine—MAOA—bipolar disorder	0.000367	0.0585	CrCbGaD
Amphetamine—SLC22A5—brain—bipolar disorder	0.000348	0.00343	CbGeAlD
Amphetamine—Phenylpropanolamine—DRD1—bipolar disorder	0.000334	0.0532	CrCbGaD
Amphetamine—Phentermine—MAOA—bipolar disorder	0.000327	0.0521	CrCbGaD
Amphetamine—Phenylpropanolamine—SLC6A3—bipolar disorder	0.000317	0.0504	CrCbGaD
Amphetamine—Pseudoephedrine—MAOA—bipolar disorder	0.00031	0.0494	CrCbGaD
Amphetamine—Selegiline—MAOA—bipolar disorder	0.000303	0.0482	CrCbGaD
Amphetamine—CYP2D6—nervous system—bipolar disorder	0.000294	0.0029	CbGeAlD
Amphetamine—Phentermine—SLC6A3—bipolar disorder	0.000282	0.0449	CrCbGaD
Amphetamine—CYP2D6—cerebellum—bipolar disorder	0.000277	0.00273	CbGeAlD
Amphetamine—Dextroamphetamine—SLC6A3—bipolar disorder	0.000269	0.0429	CrCbGaD
Amphetamine—Pseudoephedrine—SLC6A3—bipolar disorder	0.000268	0.0426	CrCbGaD
Amphetamine—Phenelzine—MAOA—bipolar disorder	0.000267	0.0425	CrCbGaD
Amphetamine—Methamphetamine—MAOA—bipolar disorder	0.000233	0.0371	CrCbGaD
Amphetamine—CYP2D6—brain—bipolar disorder	0.000225	0.00221	CbGeAlD
Amphetamine—Phentermine—SLC6A4—bipolar disorder	0.000211	0.0336	CrCbGaD
Amphetamine—Methamphetamine—SLC6A3—bipolar disorder	0.000201	0.032	CrCbGaD
Amphetamine—Pseudoephedrine—SLC6A4—bipolar disorder	0.0002	0.0318	CrCbGaD
Amphetamine—Benzphetamine—SLC6A3—bipolar disorder	0.0002	0.0318	CrCbGaD
Amphetamine—Methamphetamine—SLC6A4—bipolar disorder	0.00015	0.0239	CrCbGaD
Amphetamine—SLC6A3—Transmission across Chemical Synapses—ADCY2—bipolar disorder	9.2e-05	0.000642	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—DRD4—bipolar disorder	9.2e-05	0.000641	CbGpPWpGaD
Amphetamine—SLC6A3—NRF2 pathway—NRG1—bipolar disorder	9.1e-05	0.000634	CbGpPWpGaD
Amphetamine—CYP2A6—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	9.04e-05	0.00063	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—IMPA1—bipolar disorder	8.81e-05	0.000614	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—ADCY2—bipolar disorder	8.66e-05	0.000603	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	8.59e-05	0.000599	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—DRD2—bipolar disorder	8.57e-05	0.000597	CbGpPWpGaD
Amphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—bipolar disorder	8.48e-05	0.000591	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—TRPC3—bipolar disorder	8.36e-05	0.000583	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—TRPC3—bipolar disorder	8.34e-05	0.000581	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—DRD1—bipolar disorder	8.32e-05	0.00058	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—SLC6A4—bipolar disorder	8.32e-05	0.00058	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—DRD3—bipolar disorder	8.06e-05	0.000562	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—SNAP25—bipolar disorder	7.97e-05	0.000555	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—DRD5—bipolar disorder	7.89e-05	0.00055	CbGpPWpGaD
Amphetamine—SLC6A3—Transmission across Chemical Synapses—COMT—bipolar disorder	7.88e-05	0.000549	CbGpPWpGaD
Amphetamine—SLC6A3—Transmission across Chemical Synapses—MAOA—bipolar disorder	7.83e-05	0.000546	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—DRD4—bipolar disorder	7.82e-05	0.000545	CbGpPWpGaD
Amphetamine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	7.79e-05	0.000543	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TRPC3—bipolar disorder	7.77e-05	0.000542	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	7.61e-05	0.00053	CbGpPWpGaD
Amphetamine—CYP2A6—NRF2 pathway—NRG1—bipolar disorder	7.6e-05	0.00053	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—HTR1A—bipolar disorder	7.6e-05	0.00053	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—NDUFV2—bipolar disorder	7.49e-05	0.000522	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—IMPA1—bipolar disorder	7.46e-05	0.00052	CbGpPWpGaD
Amphetamine—CYP2A6—Biological oxidations—COMT—bipolar disorder	7.43e-05	0.000518	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—ADM—bipolar disorder	7.42e-05	0.000517	CbGpPWpGaD
Amphetamine—CYP2A6—Biological oxidations—MAOA—bipolar disorder	7.38e-05	0.000514	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	7.3e-05	0.000509	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	7.3e-05	0.000509	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—AKR1C4—bipolar disorder	7.26e-05	0.000506	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TSHB—bipolar disorder	7.23e-05	0.000504	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PDE4B—bipolar disorder	7.23e-05	0.000504	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TACR1—bipolar disorder	7.23e-05	0.000504	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—GRIN2B—bipolar disorder	7.21e-05	0.000502	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—DRD3—bipolar disorder	7.11e-05	0.000496	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	7.05e-05	0.000492	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—ADCY2—bipolar disorder	7.05e-05	0.000492	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—DRD4—bipolar disorder	6.9e-05	0.000481	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	6.81e-05	0.000475	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	6.81e-05	0.000475	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—GSK3B—bipolar disorder	6.72e-05	0.000468	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—HTR2A—bipolar disorder	6.61e-05	0.000461	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	6.6e-05	0.00046	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—NTRK1—bipolar disorder	6.6e-05	0.00046	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—NR1D1—bipolar disorder	6.52e-05	0.000454	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—TRPC3—bipolar disorder	6.51e-05	0.000454	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—ADCY2—bipolar disorder	6.5e-05	0.000453	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	6.41e-05	0.000447	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	6.41e-05	0.000446	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—ADCY2—bipolar disorder	6.36e-05	0.000443	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—IMPA2—bipolar disorder	6.36e-05	0.000443	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—NDUFV2—bipolar disorder	6.34e-05	0.000442	CbGpPWpGaD
Amphetamine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	6.25e-05	0.000436	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—NCAN—bipolar disorder	6.24e-05	0.000435	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—AKR1C4—bipolar disorder	6.14e-05	0.000428	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—SLC5A3—bipolar disorder	6.11e-05	0.000426	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—IL1B—bipolar disorder	6.06e-05	0.000422	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	6.04e-05	0.000421	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—COMT—bipolar disorder	6.04e-05	0.000421	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—HTR2A—bipolar disorder	6e-05	0.000418	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—MAOA—bipolar disorder	6e-05	0.000418	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HTR1A—bipolar disorder	5.98e-05	0.000417	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	5.95e-05	0.000415	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TAC1—bipolar disorder	5.89e-05	0.000411	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	5.84e-05	0.000407	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	5.84e-05	0.000407	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—DRD1—bipolar disorder	5.78e-05	0.000403	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HTR2C—bipolar disorder	5.78e-05	0.000403	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—TRPC3—bipolar disorder	5.76e-05	0.000402	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—ADM—bipolar disorder	5.71e-05	0.000398	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	5.65e-05	0.000394	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—NTRK2—bipolar disorder	5.62e-05	0.000392	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—DRD3—bipolar disorder	5.6e-05	0.00039	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—GSK3A—bipolar disorder	5.57e-05	0.000388	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—TSHB—bipolar disorder	5.56e-05	0.000388	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—TACR1—bipolar disorder	5.56e-05	0.000388	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	5.54e-05	0.000386	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	5.52e-05	0.000385	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—NR1D1—bipolar disorder	5.52e-05	0.000384	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—ADCY2—bipolar disorder	5.5e-05	0.000383	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	5.49e-05	0.000383	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—ADCY2—bipolar disorder	5.48e-05	0.000382	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—DRD4—bipolar disorder	5.43e-05	0.000379	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—POMC—bipolar disorder	5.28e-05	0.000368	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—NCAN—bipolar disorder	5.28e-05	0.000368	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—SLC5A3—bipolar disorder	5.17e-05	0.00036	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—ADCY2—bipolar disorder	5.11e-05	0.000356	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TCF7L2—bipolar disorder	5.1e-05	0.000355	CbGpPWpGaD
Amphetamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	5.07e-05	0.000353	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—DRD2—bipolar disorder	5.06e-05	0.000353	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—DGKH—bipolar disorder	4.88e-05	0.00034	CbGpPWpGaD
Amphetamine—CYP2A6—Biological oxidations—POMC—bipolar disorder	4.8e-05	0.000335	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—POMC—bipolar disorder	4.79e-05	0.000334	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—HTR1A—bipolar disorder	4.6e-05	0.000321	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—NTRK1—bipolar disorder	4.58e-05	0.000319	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—TAC1—bipolar disorder	4.53e-05	0.000316	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—DRD5—bipolar disorder	4.46e-05	0.000311	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—S100B—bipolar disorder	4.45e-05	0.00031	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—HTR2C—bipolar disorder	4.44e-05	0.00031	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—DRD1—bipolar disorder	4.44e-05	0.00031	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—DGKH—bipolar disorder	4.43e-05	0.000309	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CLOCK—bipolar disorder	4.42e-05	0.000308	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—RGS4—bipolar disorder	4.37e-05	0.000305	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	4.31e-05	0.0003	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—DRD3—bipolar disorder	4.3e-05	0.0003	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CACNB2—bipolar disorder	4.3e-05	0.0003	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—TSHB—bipolar disorder	4.3e-05	0.0003	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—TPH2—bipolar disorder	4.3e-05	0.0003	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—IMPA1—bipolar disorder	4.29e-05	0.000299	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—ADCY2—bipolar disorder	4.28e-05	0.000298	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—DPYD—bipolar disorder	4.23e-05	0.000295	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	4.18e-05	0.000291	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—DRD4—bipolar disorder	4.18e-05	0.000291	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—COMT—bipolar disorder	4.17e-05	0.00029	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—MAOA—bipolar disorder	4.14e-05	0.000288	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—GSK3B—bipolar disorder	4.11e-05	0.000286	CbGpPWpGaD
Amphetamine—CYP2D6—Metapathway biotransformation—COMT—bipolar disorder	4.11e-05	0.000286	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—DRD5—bipolar disorder	4.05e-05	0.000282	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—RGS4—bipolar disorder	3.97e-05	0.000277	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CACNA1C—bipolar disorder	3.94e-05	0.000274	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—NRG1—bipolar disorder	3.93e-05	0.000274	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PIK3C2A—bipolar disorder	3.84e-05	0.000267	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—ADCY2—bipolar disorder	3.79e-05	0.000264	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CLOCK—bipolar disorder	3.74e-05	0.00026	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—NDUFV2—bipolar disorder	3.65e-05	0.000254	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—TSHB—bipolar disorder	3.64e-05	0.000254	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—TPH2—bipolar disorder	3.64e-05	0.000254	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CACNB2—bipolar disorder	3.64e-05	0.000254	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—POMC—bipolar disorder	3.6e-05	0.000251	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—DPYD—bipolar disorder	3.58e-05	0.00025	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	3.58e-05	0.00025	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—IMPA2—bipolar disorder	3.56e-05	0.000248	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HTR2A—bipolar disorder	3.54e-05	0.000247	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—AKR1C4—bipolar disorder	3.54e-05	0.000246	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—SNAP25—bipolar disorder	3.44e-05	0.00024	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—TRPC3—bipolar disorder	3.38e-05	0.000236	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CACNA1C—bipolar disorder	3.33e-05	0.000232	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3C2A—bipolar disorder	3.25e-05	0.000226	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—ADM—bipolar disorder	3.22e-05	0.000225	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—NR1D1—bipolar disorder	3.18e-05	0.000221	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—TSHB—bipolar disorder	3.14e-05	0.000219	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PDE4B—bipolar disorder	3.14e-05	0.000219	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—TACR1—bipolar disorder	3.14e-05	0.000219	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—TRPC3—bipolar disorder	3.07e-05	0.000214	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ADCY2—bipolar disorder	3.05e-05	0.000212	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—NCAN—bipolar disorder	3.04e-05	0.000212	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—SLC5A3—bipolar disorder	2.98e-05	0.000207	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—ADM—bipolar disorder	2.93e-05	0.000204	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—SNAP25—bipolar disorder	2.91e-05	0.000203	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	2.86e-05	0.000199	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—GSK3B—bipolar disorder	2.85e-05	0.000199	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PDE4B—bipolar disorder	2.85e-05	0.000199	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—TSHB—bipolar disorder	2.85e-05	0.000199	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—TACR1—bipolar disorder	2.85e-05	0.000199	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AKR1C4—bipolar disorder	2.84e-05	0.000198	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—POMC—bipolar disorder	2.83e-05	0.000197	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—INS—bipolar disorder	2.81e-05	0.000196	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—HTR2A—bipolar disorder	2.73e-05	0.00019	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—POMC—bipolar disorder	2.69e-05	0.000188	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—DGKH—bipolar disorder	2.62e-05	0.000182	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—COMT—bipolar disorder	2.61e-05	0.000182	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HTR1A—bipolar disorder	2.6e-05	0.000181	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—MAOA—bipolar disorder	2.59e-05	0.00018	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ADCY2—bipolar disorder	2.58e-05	0.00018	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—TAC1—bipolar disorder	2.56e-05	0.000179	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HTR2C—bipolar disorder	2.51e-05	0.000175	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—DRD1—bipolar disorder	2.51e-05	0.000175	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—DRD3—bipolar disorder	2.43e-05	0.00017	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—IMPA1—bipolar disorder	2.41e-05	0.000168	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—DRD5—bipolar disorder	2.39e-05	0.000167	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HTR1A—bipolar disorder	2.36e-05	0.000165	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—DRD4—bipolar disorder	2.36e-05	0.000165	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—RGS4—bipolar disorder	2.35e-05	0.000164	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—TAC1—bipolar disorder	2.33e-05	0.000162	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HTR2C—bipolar disorder	2.28e-05	0.000159	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—DRD1—bipolar disorder	2.28e-05	0.000159	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—ADCY2—bipolar disorder	2.22e-05	0.000155	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—DRD3—bipolar disorder	2.21e-05	0.000154	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—COMT—bipolar disorder	2.21e-05	0.000154	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—MAOA—bipolar disorder	2.19e-05	0.000153	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—POMC—bipolar disorder	2.18e-05	0.000152	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CLOCK—bipolar disorder	2.15e-05	0.00015	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—DRD4—bipolar disorder	2.14e-05	0.000149	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—MTHFR—bipolar disorder	2.11e-05	0.000147	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—TSHB—bipolar disorder	2.1e-05	0.000146	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CACNB2—bipolar disorder	2.1e-05	0.000146	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—TPH2—bipolar disorder	2.1e-05	0.000146	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—DPYD—bipolar disorder	2.06e-05	0.000144	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NDUFV2—bipolar disorder	2.05e-05	0.000143	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—ADCY2—bipolar disorder	2.02e-05	0.000141	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—AKR1C4—bipolar disorder	1.98e-05	0.000138	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CACNA1C—bipolar disorder	1.92e-05	0.000134	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3C2A—bipolar disorder	1.87e-05	0.00013	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TRPC3—bipolar disorder	1.81e-05	0.000126	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—MTHFR—bipolar disorder	1.78e-05	0.000124	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NR1D1—bipolar disorder	1.78e-05	0.000124	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ADM—bipolar disorder	1.73e-05	0.000121	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NCAN—bipolar disorder	1.7e-05	0.000119	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—POMC—bipolar disorder	1.69e-05	0.000118	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PDE4B—bipolar disorder	1.69e-05	0.000117	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TSHB—bipolar disorder	1.69e-05	0.000117	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TACR1—bipolar disorder	1.69e-05	0.000117	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—INS—bipolar disorder	1.68e-05	0.000117	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—SNAP25—bipolar disorder	1.68e-05	0.000117	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SLC5A3—bipolar disorder	1.67e-05	0.000116	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HTR2A—bipolar disorder	1.54e-05	0.000107	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ADCY2—bipolar disorder	1.48e-05	0.000103	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—POMC—bipolar disorder	1.43e-05	9.94e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—INS—bipolar disorder	1.42e-05	9.89e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HTR2A—bipolar disorder	1.4e-05	9.75e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR1A—bipolar disorder	1.4e-05	9.73e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TAC1—bipolar disorder	1.37e-05	9.58e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR2C—bipolar disorder	1.35e-05	9.39e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—DRD1—bipolar disorder	1.35e-05	9.39e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NTRK2—bipolar disorder	1.31e-05	9.14e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—DRD3—bipolar disorder	1.31e-05	9.1e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GSK3A—bipolar disorder	1.3e-05	9.06e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—COMT—bipolar disorder	1.27e-05	8.86e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—DRD4—bipolar disorder	1.27e-05	8.83e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—MAOA—bipolar disorder	1.26e-05	8.79e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—POMC—bipolar disorder	1.23e-05	8.58e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CLOCK—bipolar disorder	1.21e-05	8.41e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ADCY2—bipolar disorder	1.19e-05	8.31e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TCF7L2—bipolar disorder	1.19e-05	8.28e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—TPH2—bipolar disorder	1.18e-05	8.2e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—TSHB—bipolar disorder	1.18e-05	8.2e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CACNB2—bipolar disorder	1.18e-05	8.2e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—DPYD—bipolar disorder	1.16e-05	8.06e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—POMC—bipolar disorder	1.12e-05	7.79e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CACNA1C—bipolar disorder	1.08e-05	7.5e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NTRK1—bipolar disorder	1.07e-05	7.45e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	1.05e-05	7.31e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—S100B—bipolar disorder	1.04e-05	7.24e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—MTHFR—bipolar disorder	1.03e-05	7.16e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SNAP25—bipolar disorder	9.4e-06	6.55e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NRG1—bipolar disorder	9.17e-06	6.39e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ADCY2—bipolar disorder	8.32e-06	5.8e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR2A—bipolar disorder	8.27e-06	5.76e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—POMC—bipolar disorder	8.21e-06	5.72e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—INS—bipolar disorder	8.17e-06	5.69e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—COMT—bipolar disorder	7.12e-06	4.97e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—MAOA—bipolar disorder	7.07e-06	4.93e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GSK3B—bipolar disorder	6.66e-06	4.64e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—POMC—bipolar disorder	6.6e-06	4.6e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—INS—bipolar disorder	6.56e-06	4.58e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—MTHFR—bipolar disorder	5.76e-06	4.01e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—POMC—bipolar disorder	4.61e-06	3.21e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—INS—bipolar disorder	4.58e-06	3.19e-05	CbGpPWpGaD
